Astrana Health Inc. - Common Stock (ASTH)

ECGI Holdings (OTC: ECGI) is featured in an AINewsWire editorial examining the shift toward preventive, coordinated healthcare and the growing role of artificial intelligence (“AI”) in improving patient outcomes and managing costs. The editorial highlights ECGI’s completed acquisition of Avanta Group, an emerging platform combining a developing Medicare Advantage health plan, management services and AI-driven healthcare technology. The acquisition positions ECGI to pursue opportunities in a U.S. healthcare market that reached $5.3 trillion in spending in 2024, with Medicare Advantage payments projected to reach $574 billion in 2026. The editorial also discusses the potential for Avanta’s integrated platform to improve care coordination, identify gaps in treatment and streamline administrative processes, while noting that regulatory approvals and licenses are still required before its health plan can begin operating.

AINewsWire Editorial Coverage : In today’s healthcare landscape, treating sickness after the fact is giving way to stopping it before it starts. U.S. health spending hit $5.3 trillion in 2024, and Medicare Advantage enrolls 35.2 million people today, equal to 55% of those eligible. For 2026, KFF estimates Medicare Advantage payments will hit $574 billion, giving health plans strong financial incentive to keep their members well. A new category of company is emerging to meet that shift. ECGI Holdings Inc. (OTC: ECGI) ( profile ) has finalized its purchase of Avanta Group, an emerging platform combining a Medicare Advantage health plan with management services and AI-driven health technology. Through the acquisition, ECGI gains direct entry into coordinated, proactive care right as the broader industry looks for better ways to deliver it. ECGI now operates in the same space as established names in U.S. managed healthcare, including sector leaders Centene Corporation (NYSE: CNC), Molina Healthcare Inc. (NYSE: MOH), Astrana Health Inc. (NASDAQ: ASTH) and Alignment Healthcare Inc. (NASDAQ: ALHC).

NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

AUSTIN, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: In today’s healthcare landscape, treating sickness after the fact is giving way to stopping it before it starts. U.S. health spending hit $5.3 trillion in 2024, and Medicare Advantage enrolls 35.2 million people today, equal to 55% of those eligible. For 2026, KFF estimates Medicare Advantage payments will hit $574 billion, giving health plans strong financial incentive to keep their members well. A new category of company is emerging to meet that shift. ECGI Holdings Inc. (OTC: ECGI) (profile) has finalized its purchase of Avanta Group, an emerging platform combining a Medicare Advantage health plan with management services and AI-driven health technology. Through the acquisition, ECGI gains direct entry into coordinated, proactive care right as the broader industry looks for better ways to deliver it. ECGI now operates in the same space as established names in U.S. managed healthcare, including sector leaders Centene Corporation (NYSE: CNC), Molina Healthcare Inc. (NYSE: MOH), Astrana Health Inc. (NASDAQ: ASTH) and Alignment Healthcare Inc. (NASDAQ: ALHC).

NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or “the Company”) (NASDAQ: ASTH) for violations of the securities laws.

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Astrana Health, Inc. (NASDAQ: ASTH) (“Astrana” or the “Company”) for potential violations of the federal securities laws.

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:MSFT),(NASDAQ:ASTH),(NASDAQ:RXRX),(NASDAQ:MDAI) EQNX::TICKER_END